- Home
- FOXF vs STAA Comparison
FOXF vs STAA Comparison
Compare FOXF & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXF
- STAA
- Stock Information
- Founded
- FOXF 2007
- STAA 1982
- Country
- FOXF United States
- STAA United States
- Employees
- FOXF N/A
- STAA N/A
- Industry
- FOXF Motor Vehicles
- STAA Ophthalmic Goods
- Sector
- FOXF Consumer Discretionary
- STAA Health Care
- Exchange
- FOXF Nasdaq
- STAA Nasdaq
- Market Cap
- FOXF N/A
- STAA 850.9M
- IPO Year
- FOXF N/A
- STAA N/A
- Fundamental
- Price
- FOXF $28.39
- STAA $17.20
- Analyst Decision
- FOXF Buy
- STAA Hold
- Analyst Count
- FOXF 7
- STAA 8
- Target Price
- FOXF $36.43
- STAA $27.17
- AVG Volume (30 Days)
- FOXF 491.2K
- STAA 776.5K
- Earning Date
- FOXF 07-31-2025
- STAA 08-06-2025
- Dividend Yield
- FOXF N/A
- STAA N/A
- EPS Growth
- FOXF N/A
- STAA N/A
- EPS
- FOXF N/A
- STAA N/A
- Revenue
- FOXF $1,415,479,000.00
- STAA $279,134,000.00
- Revenue This Year
- FOXF $5.17
- STAA N/A
- Revenue Next Year
- FOXF $6.34
- STAA $29.34
- P/E Ratio
- FOXF N/A
- STAA N/A
- Revenue Growth
- FOXF 1.26
- STAA N/A
- 52 Week Low
- FOXF $17.95
- STAA $13.50
- 52 Week High
- FOXF $54.86
- STAA $49.86
- Technical
- Relative Strength Index (RSI)
- FOXF 65.39
- STAA 49.46
- Support Level
- FOXF $27.05
- STAA $16.52
- Resistance Level
- FOXF $28.72
- STAA $18.01
- Average True Range (ATR)
- FOXF 1.07
- STAA 0.68
- MACD
- FOXF 0.22
- STAA 0.07
- Stochastic Oscillator
- FOXF 89.15
- STAA 55.49
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.